Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Capital Leases (2022 - 2026)

Rockwell Medical filings provide 7 years of Capital Leases readings, the most recent being $304000.0 for Q4 2025.

  • On a quarterly basis, Capital Leases fell 67.35% to $304000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $304000.0, a 67.35% decrease, with the full-year FY2025 number at $304000.0, down 67.35% from a year prior.
  • Capital Leases hit $304000.0 in Q4 2025 for Rockwell Medical, down from $423000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.1 million in Q4 2022 to a low of $304000.0 in Q4 2025.
  • Median Capital Leases over the past 4 years was $1.2 million (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Capital Leases: decreased 26.72% in 2023 and later crashed 67.35% in 2025.
  • Rockwell Medical's Capital Leases stood at $2.1 million in 2022, then dropped by 26.72% to $1.5 million in 2023, then tumbled by 39.15% to $931000.0 in 2024, then crashed by 67.35% to $304000.0 in 2025.
  • The last three reported values for Capital Leases were $304000.0 (Q4 2025), $423000.0 (Q3 2025), and $614000.0 (Q2 2025) per Business Quant data.